Syneos Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Syneos Health generated cash of $0, which is less than the previous year. Cash used in financing activities reached the amount of $0 last year.
Cash Flow
| 2014 | 131.44M | -27.85M | -67.69M |
|---|---|---|---|
| 2015 | 204.74M | -21.11M | -211.39M |
| 2016 | 109.33M | -31.35M | -53.31M |
| 2017 | 198.25M | -1.72B | 1.73B |
| 2018 | 303.44M | -145.48M | -319.35M |
| 2019 | 318.48M | -81.66M | -215.46M |
| 2020 | 425.49M | -504.08M | 178.26M |
| 2021 | 450.27M | -340.34M | -277.57M |
| 2022 | 426.98M | -105.63M | -339.15M |
| 2023 | 0 | 0 | 0 |
SYNH Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 0 | 106.47M | 272.17M | 163.68M | 155.93M | 321.97M | 102.47M | 85.01M | 126.45M | 96.97M |
Operating activities | ||||||||||
Net income | 0 | 266.49M | 234.83M | 192.78M | 131.25M | 24.28M | -138.46M | 112.63M | 117.04M | -23.47M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 247.17M | 235.62M | 222.35M | 242.46M | 273.68M | 179.93M | 59.20M | 56.01M | 54.54M |
Stock-based compensation expense | 0 | 57.27M | 65.20M | 58.49M | 55.19M | 34.32M | 59.69M | 14.02M | 5.07M | 3.37M |
| Deferred income tax benefit | 0 | 57.27M | 65.20M | 58.49M | 55.19M | 34.32M | 59.69M | 14.02M | 5.07M | 3.37M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -88.25M | -109.36M | 16.31M | -120.38M | -97.62M | 31.65M | -103.74M | -54.07M | -24.25M |
Inventories | 0 | 0 | -24.62M | 2.56M | -28.31M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 20.92M | 24.62M | -2.56M | 28.31M | 60.02M | -16.98M | 6.65M | 8.18M | 25.74M |
Cash generated by operating activities | 0 | 426.98M | 450.27M | 425.49M | 318.48M | 303.44M | 198.25M | 109.33M | 204.74M | 131.44M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -93.45M | -56.84M | -50.01M | -63.97M | -54.59M | -43.89M | -31.35M | -21.11M | -25.55M |
Acquisitions Net | 0 | -12.17M | -284.66M | -454.07M | -17.68M | -90.89M | -1.67B | 0 | 0 | -2.30M |
Cash generated by investing activities | 0 | -105.63M | -340.34M | -504.08M | -81.66M | -145.48M | -1.72B | -31.35M | -21.11M | -27.85M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 23.70M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 156.11M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -375K |
Repurchases of common stock | 0 | -149.96M | -117.52M | -70.15M | -56.71M | -74.98M | 0 | -64.5M | -286.42M | -3.42M |
Repayments of term debt | 0 | 0 | -823.05M | -650.32M | 0 | -424.36M | 0 | -105M | 0 | -503.16M |
Cash used in financing activities | 0 | -339.15M | -277.57M | 178.26M | -215.46M | -319.35M | 1.73B | -53.31M | -211.39M | -67.69M |
Net Change In Cash | 0 | 5.52M | -165.69M | 108.48M | 7.75M | -166.04M | 218.79M | 17.46M | -41.44M | 29.48M |
Cash at end of period | 0 | 112.00M | 106.47M | 272.17M | 163.68M | 155.93M | 321.26M | 102.47M | 85.01M | 126.45M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |